- Home
- PYPD vs MYND Comparison
PYPD vs MYND Comparison
Compare PYPD & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- MYND
- Stock Information
- Founded
- PYPD 2008
- MYND 1998
- Country
- PYPD Israel
- MYND United States
- Employees
- PYPD N/A
- MYND N/A
- Industry
- PYPD Medical/Dental Instruments
- MYND Other Consumer Services
- Sector
- PYPD Health Care
- MYND Real Estate
- Exchange
- PYPD Nasdaq
- MYND Nasdaq
- Market Cap
- PYPD 34.8M
- MYND 34.2M
- IPO Year
- PYPD 2020
- MYND 2017
- Fundamental
- Price
- PYPD $3.49
- MYND $0.78
- Analyst Decision
- PYPD Strong Buy
- MYND
- Analyst Count
- PYPD 5
- MYND 0
- Target Price
- PYPD $12.00
- MYND N/A
- AVG Volume (30 Days)
- PYPD 52.0K
- MYND 143.9K
- Earning Date
- PYPD 11-12-2025
- MYND 08-27-2025
- Dividend Yield
- PYPD N/A
- MYND N/A
- EPS Growth
- PYPD N/A
- MYND N/A
- EPS
- PYPD N/A
- MYND N/A
- Revenue
- PYPD N/A
- MYND $209,800,000.00
- Revenue This Year
- PYPD N/A
- MYND N/A
- Revenue Next Year
- PYPD N/A
- MYND N/A
- P/E Ratio
- PYPD N/A
- MYND N/A
- Revenue Growth
- PYPD N/A
- MYND N/A
- 52 Week Low
- PYPD $2.30
- MYND $0.53
- 52 Week High
- PYPD $3.93
- MYND $3.89
- Technical
- Relative Strength Index (RSI)
- PYPD 54.23
- MYND 59.02
- Support Level
- PYPD $3.35
- MYND $0.71
- Resistance Level
- PYPD $3.54
- MYND $0.84
- Average True Range (ATR)
- PYPD 0.12
- MYND 0.08
- MACD
- PYPD 0.00
- MYND 0.02
- Stochastic Oscillator
- PYPD 75.49
- MYND 73.65
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.